Authors
Latest:
The Future of Lipoprotein Apheresis, with Laurence Sperling, MD, and Eugenia Gianos, MDIn part 3 of our Special Report on lipoprotein apheresis, Sperling and Gianos discuss future considerations for use and the evolving landscape of lipid management.
Latest:
The Future of Treatment for Diabetic Macular EdemaDr Theodore Leng discusses what the future may hold for patients with diabetic macular edema.
Latest:
Measuring Patient Satisfaction with Inflammatory Bowel Disease Treatments and Communication Regarding Treatment ChangesSilvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, conclude by sharing their approaches to evaluating patient satisfaction and expectations when providing care for ulcerative colitis and Crohn's disease, while also touching upon the importance of discussing the potential need for escalating or switching therapies to better manage the underlying disease processes.
Latest:
Exploring Oral Systemic Therapies For Plaque Psoriasis: Efficacy, Safety, and Clinical ConsiderationsLauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.
Latest:
Prospect of Psychedelic Therapies in Psychiatry, with Gus Alva, MDIn this part of our 5-part series, Gus Alva, MD discusses the next steps in research for long-term effects and broader applications of MDMA-assisted therapy.
Latest:
Sick Day Rules in Nephrology, with Kim Zuber, PA-C, and Jane Davis, DNPIn their latest column, Kim Zuber, PA-C, and Jane Davis, DNP, break down the concept of "sick day rules" and what this means for providers caring for those with kidney disease.
Latest:
Initiating Conversations with Patients about Anti-VEGF AgentsKey opinion leaders emphasize important considerations when discussing the safety of anti-VEGF agents with patients and highlight unmet needs in nonproliferative diabetic retinopathy treatments.
Latest:
Clinical trial data on IgAN for therapiesGerald B. Appel, MD, discusses the changing treatment landscape of IgAN.
Latest:
Looking Into the Future of Lipid ManagementDr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Latest:
Unmet Needs, Future Research in Schizophrenia and Muscarinic AgonistsIn part 5 of 5, experts discuss ongoing unmet needs and future research priorities in schizophrenia management.
Latest:
Physician Advice for Patients With SCDWally Smith, MD, shares his take-home points for patients with sickle cell disease and urges to get tested for sickle cell trait.
Latest:
Final Thoughts on the Opioid Crisis and Normalizing NaloxoneThe multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Latest:
Collaboration and Communication Across the Healthcare TeamThe expert panel concludes its discussion with insights on how collaboration and communication across various healthcare specialties improve the care of patients treated for iron deficiency anemia.
Latest:
Take-Home Messages for the Management of Crohn’s DiseaseExperts in gastroenterology share advice for the treatment of patients of Crohn’s disease.
Latest:
Clinical Pearls for the Management of Wet AMDA panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
Latest:
Closing RemarksPanelists discuss how their approaches to treating patients with rheumatoid arthritis focus on personalized strategies that prioritize achieving remission while carefully monitoring safety and efficacy outcomes.
Latest:
Steroids and Immunosuppressive Agents for CSUPanelists discuss how steroids can play a role in the management of chronic spontaneous urticaria (CSU), while emphasizing that practitioners should exercise caution due to potential adverse effects and the need for careful monitoring when using systemic steroids.
Latest:
Novel Investigational Approaches For the Treatment of Neovascular AMDDr Paul Hahn and Dr Michael Cohen explore upcoming treatments featuring innovative mechanisms of action and novel delivery systems for addressing neovascular AMD.
Latest:
Final Thoughts on Management of Nasal PolyposisDrs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri share takeaway thoughts on the management of nasal polyposis.
Latest:
Treating Dry Eye in The Presence of Ocular ComorbiditiesExperts discuss the management of dry eye in the presence of concurrent ocular conditions, as well as managing dry eye before undergoing cataract and refractive surgery.
Latest:
Systemic Lupus Erythematosus Treatment Advances: AnifrolumabThe rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.
Latest:
Injunction Letters May Reduce Clinician Overprescription of BenzodiazepinesReductions in prescribed benzodiazepines were especially noted in continuing prescriptions.
Latest:
Appropriate Guidance for CRC Screening Age, Role of Advocacy OrganizationsIn part 5 of our 5-part discussion, experts discuss their perspective on appropriate guidance for screening age and the future of CRC advocacy.
Latest:
The APAC Recap: AHA Hypertension Scientific Sessions 2024In this episode, John Giacona, PhD, PA-C, shares insights from the 2024 AHA Hypertension Scientific Sessions, focusing on primary aldosteronism and renal denervation.
Latest:
Emerging Agents for Heart Failure TreatmentJames Januzzi, MD, and Javed Butler, MD, MPH, MBA, discuss emerging agents, vericiguat and intravenous (IV) iron, in the treatment landscape for heart failure with reduced ejection fraction and advice for community physicians managing patients with heart failure.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
